ReviewPlanta2025
Enhancing essential oils: advanced extraction, sustainability, and nanotechnology for optimal use.
Review in Planta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Redox-Regulating Propolis- and Honey-Containing Hydrogels in Osteoarthritis.Antioxidants (Basel, Switzerland) · 2026Review
- Green Management Strategies forBiology · 2026Review
- Effect of Distillation Time on the Yield and Chemical Composition of Leaf Essential Oil fromPlants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MAIN
conclusionOur findings provide new insights into how integrating advanced extraction methods with nanotechnology enhances essential oil stability, bioavailability, and safety, offering significant potential for sustainable pharmaceutical, therapeutic, and environmental applications Essential oils (EOs), volatile secondary metabolites extracted from plant parts such as leaves, seeds, and roots, are gaining prominence due to their broad therapeutic potential-including antifungal, antibacterial, anti-inflammatory, and antioxidant properties. Conventional extraction techniques like steam distillation and cold pressing typically yield 0.1-2.0% EO depending on plant species, part used, and method applied. However, EOs suffer from physicochemical limitations such as volatility, oxidative instability, and low bioavailability, which restrict their direct application in pharmaceutical and consumer products. Recent advances in nanotechnology-particularly nanoemulsions, liposomes, and polymeric nanoparticles-have demonstrated the ability to enhance EO bioavailability by up to 40%, prolong release times, and improve chemical stability under environmental stress. These encapsulation systems also reduce cytotoxicity and degradation while facilitating targeted delivery. This review critically evaluates modern EO extraction strategies, including green and sustainable approaches, and discusses nanoencapsulation technologies that optimize EO functionality. The emphasis focuses on safety considerations, physicochemical enhancements, and the translational potential of integrating EO-nanotechnology in medical and environmental applications.
Indexed as
Identifiers
40754600What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.